|
1
|
Tsui KC, Chiang TH, Wang JS, et al:
Flavonoids from Gynostemma pentaphyllum exhibit differential
induction of cell cycle arrest in H460 and A549 cancer cells.
Molecules. 19:17663–17681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu W, Lu X, He G, et al: Protective roles
of Gadd45 and MDM2 in blueberry anthocyanins mediated DNA repair of
fragmented and non-fragmented DNA damage in UV-irradiated HepG2
cells. Int J Mol Sci. 14:21447–21462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yasui Y, Hosokawa M, Sahara T, et al:
Bitter gourd seed fatty acid rich in 9c, 11t, 13t-conjugated
linolenic acid induces apoptosis and up-regulates the GADD45, p53
and PPARgamma in human colon cancer Caco-2 cells. Prostaglandins
Leukot Essent Fatty Acids. 73:113–119. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aoubala M, Murray-Zmijewski F, Khoury MP,
et al: p53 directly transactivates Δ133p53α, regulating cell fate
outcome in response to DNA damage. Cell Death Differ. 18:248–258.
2011. View Article : Google Scholar :
|
|
5
|
Sauer M, Bretz AC, Beinoraviciute-Kellner
R, et al: C-terminal diversity within the p53 family accounts for
differences in DNA binding and transcriptional activity. Nucleic
Acids Res. 36:1900–1912. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Courtois S, Verhaegh G, North S, et al:
DeltaN-p53, a natural isoform of p53 lacking the first
transactivation domain, counteracts growth suppression by wild-type
p53. Oncogene. 21:6722–6728. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chan WM and Poon RY The p53 Isoform
Deltap53 lacks intrinsic transcriptional activity and reveals the
critical role of nuclear import in dominant-negative activity.
Cancer Res. 67:1959–1969. 2007. View Article : Google Scholar
|
|
8
|
Marcel V, Perrier S, Aoubala M, et al:
Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53
transcript. FEBS Lett. 584:4463–4468. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song W, Huo SW, Lü JJ, et al: Expression
of p53 isoforms in renal cell carcinoma. Chin Med J (Engl).
122:921–926. 2009.
|
|
10
|
Bourdon JC, Khoury MP, Diot A, et al: p53
mutant breast cancer patients expressing p53γ have as good a
prognosis as wild-type p53 breast cancer patients. Breast Cancer
Res. 13:R72011. View
Article : Google Scholar
|
|
11
|
Chambers SK and Martinez JD: The
significance of p53 isoform expression in serous ovarian cancer.
Future Oncol. 8:683–686. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Philipova T, Baryawno N, Hartmann W, et
al: Differential forms of p53 in medulloblastoma primary tumors,
cell lines and xenografts. Int J Oncol. 38:843–849. 2011.
|
|
13
|
Goldschneider D, Horvilleur E, Plassa LF,
et al: Expression of C-terminal deleted p53 isoforms in
neuroblastoma. Nucleic Acids Res. 34:5603–5612. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Avery-Kiejda KA, Zhang XD, Adams LJ, et
al: Small molecular weight variants of p53 are expressed in human
melanoma cells and are induced by the DNA-damaging agent cisplatin.
Clin Cancer Res. 14:1659–1668. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Boldrup L, Bourdon JC, Coates PJ, Sjöström
B and Nylander K: Expression of p53 isoforms in squamous cell
carcinoma of the head and neck. Eur J Cancer. 43:617–623. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ånensen N, Hjelle SM, Van Belle W, et al:
Correlation analysis of p53 protein isoforms with NPM1/FLT3
mutations and therapy response in acute myeloid leukemia. Oncogene.
31:1533–1545. 2012. View Article : Google Scholar
|
|
17
|
Bourdon JC, Fernandes K, Murray-Zmiewski
F, et al: p53 isoforms can regulate p53 transcriptional activity.
Genes Dev. 19:2122–2137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bernard H, Garmy-Susini B, Ainaoui N, et
al: The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour
progression. Oncogene. 32:2150–2160. 2013. View Article : Google Scholar
|
|
19
|
Sigal A and Rotter V: Oncogenic mutations
of the p53 tumor suppressor: the demons of the guardian of the
genome. Cancer Res. 60:6788–6793. 2000.
|
|
20
|
Terrier O, Marcel V, Cartet G, et al:
Influenza A viruses control expression of proviral human p53
isoforms p53β and Delta133p53α. J Virol. 86:8452–8460. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Campbell HG, Slatter TL, Jeffs A, et al:
Does Δ133p53 isoform trigger inflammation and autoimmunity? Cell
Cycle. 11:446–450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Berglind H, Pawitan Y, Kato S, Ishioka C
and Soussi T: Analysis of p53 mutation status in human cancer cell
lines: a paradigm for cell line cross-contamination. Cancer Biol
Ther. 7:699–708. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hofstetter G, Berger A, Schuster E, et al:
Δ133p53 is an independent prognostic marker in p53 mutant advanced
serous ovarian cancer. Br J Cancer. 105:1593–1599. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Solomon H, Sharon M and Rotter V:
Modulation of alternative splicing contributes to cancer
development: focusing on p53 isoforms, p53β and p53γ. Cell Death
Differ. 21:1347–1349. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Marcel V, Fernandes K, Terrier O, Lane DP
and Bourdon JC: Modulation of p53β and p53γ expression by
regulating the alternative splicing of TP53 gene modifies cellular
response. Cell Death Differ. 21:1377–1387. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hofstetter G, Berger A, Berger R, et al:
The N-terminally truncated p53 isoform Δ40p53 influences prognosis
in mucinous ovarian cancer. Int J Gynecol Cancer. 22:372–379. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Graupner V, Schulze-Osthoff K, Essmann F
and Jänicke RU: Functional characterization of p53beta and
p53gamma, two isoforms of the tumor suppressor p53. Cell Cycle.
8:1238–1248. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Camus S, Ménendez S, Fernandes K, et al:
The p53 isoforms are differentially modified by Mdm2. Cell Cycle.
11:1646–1655. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Marine JC and Lozano G: Mdm2-mediated
ubiquitylation: p53 and beyond. Cell Death Differ. 17:93–102. 2010.
View Article : Google Scholar
|
